Total Payments
$7,917
2021 Payments
$722.46
Companies
40
Transactions
483
Medicare Patients
2,057
Medicare Billing
$207,789
Payment Breakdown by Category
Food & Beverage$7,902 (99.8%)
Education$15.46 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,902 | 480 | 99.8% |
| Education | $15.46 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $879.81 | 46 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $739.12 | 67 | $0 (2021) |
| PFIZER INC. | $717.66 | 59 | $0 (2021) |
| Novo Nordisk Inc | $607.22 | 42 | $0 (2021) |
| Amgen Inc. | $590.50 | 25 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $585.58 | 24 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $454.77 | 22 | $0 (2020) |
| Allergan, Inc. | $301.06 | 17 | $0 (2020) |
| Lilly USA, LLC | $296.04 | 17 | $0 (2021) |
| AbbVie Inc. | $271.70 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $722.46 | 35 | Biohaven Pharmaceuticals, Inc. ($122.83) |
| 2020 | $1,087 | 55 | Amgen Inc. ($219.82) |
| 2019 | $1,774 | 119 | Merck Sharp & Dohme Corporation ($272.17) |
| 2018 | $1,881 | 130 | Boehringer Ingelheim Pharmaceuticals, Inc. ($240.52) |
| 2017 | $2,453 | 144 | AstraZeneca Pharmaceuticals LP ($291.24) |
All Payment Transactions
483 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2021 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUZONE QUADRIVALENT, ADACEL | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Vaccines | ||||||
| 08/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 08/12/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Neurology | ||||||
| 07/23/2021 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: HIV | ||||||
| 07/22/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: WOMENS HEALTH | ||||||
| 07/21/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: RESPIRATORY | ||||||
| 06/29/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $102.54 | General |
| Category: PRIMARY CARE | ||||||
| 06/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Neuroscience | ||||||
| 06/21/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.74 | General |
| Category: Opioid Analgesic | ||||||
| 06/15/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Respiratory | ||||||
| 06/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, TRIJARDY XR | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: DIABETES | ||||||
| 06/08/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Diabetes | ||||||
| 05/27/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/25/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/24/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
| 05/13/2021 | Medicure Pharma Inc. | ZYPITAMAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.35 | General |
| Category: HMG-CoA reductase inhibitor | ||||||
| 05/06/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: VACCINE | ||||||
| 05/03/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/29/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/26/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $24.14 | General |
| Category: Neurology | ||||||
| 04/20/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 04/01/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 710 | 1,132 | $161,263 | $84,184 |
| 2020 | 12 | 1,347 | 2,131 | $257,766 | $123,605 |
Total Patients
2,057
Total Services
3,263
Medicare Billing
$207,789
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 405 | 763 | $122,040 | $64,283 | 52.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 184 | 241 | $28,920 | $13,899 | 48.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 36 | 36 | $6,480 | $5,144 | 79.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 67 | 71 | $3,550 | $773.03 | 21.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 18 | 21 | $273.00 | $84.42 | 30.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 456 | 1,066 | $170,560 | $77,956 | 45.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 283 | 428 | $51,360 | $22,633 | 44.1% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 151 | 152 | $10,640 | $9,269 | 87.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 30 | 30 | $5,400 | $3,812 | 70.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 159 | 161 | $6,440 | $2,927 | 45.5% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 12 | 12 | $3,300 | $2,762 | 83.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 17 | 17 | $2,550 | $1,879 | 73.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 87 | 94 | $4,700 | $1,233 | 26.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 26 | 27 | $1,080 | $489.06 | 45.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 15 | 22 | $660.00 | $251.10 | 38.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 80 | 85 | $595.00 | $246.96 | 41.5% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 31 | 37 | $481.00 | $147.06 | 30.6% |
About Dr. Howard Schultz, MD
Dr. Howard Schultz, MD is a Family Medicine healthcare provider based in Gambrills, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164450920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Schultz, MD has received a total of $7,917 in payments from pharmaceutical and medical device companies, with $722.46 received in 2021. These payments were reported across 483 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,902).
As a Medicare-enrolled provider, Schultz has provided services to 2,057 Medicare beneficiaries, totaling 3,263 services with total Medicare billing of $207,789. Data is available for 2 years (2020–2021), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Gambrills, MD
- Active Since 06/29/2006
- Last Updated 03/19/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164450920
Products in Payments
- FARXIGA (Drug) $795.25
- JARDIANCE (Drug) $514.87
- CHANTIX (Drug) $408.73
- JANUVIA (Drug) $360.60
- Ozempic (Drug) $351.92
- SOLIQUA (Drug) $230.27
- Aimovig (Biological) $211.18
- XARELTO (Drug) $199.48
- Prolia (Biological) $181.87
- Vascepa (Drug) $178.32
- TRULICITY (Drug) $177.74
- TOUJEO (Drug) $176.22
- Livalo (Drug) $163.08
- Trintellix (Drug) $162.33
- EVENITY (Biological) $153.30
- ASMANEX (Drug) $150.08
- XIFAXAN (Drug) $142.01
- MYDAYIS (Drug) $138.17
- VIMOVO (Drug) $136.88
- ELIQUIS (Drug) $131.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Gambrills
Kimberly Wallace, Md, MD
Family Medicine — Payments: $10,034
Family Medicine $10,034
Peter Su, Md, MD
Family Medicine — Payments: $8,829
Family Medicine $8,829
Tara Muscovich, Md, MD
Family Medicine — Payments: $5,145
Family Medicine $5,145
Michelle Skinner, D.o, D.O
Family Medicine — Payments: $530.12
Family Medicine $530.12
Dr. Ian Shantz, Md, MD
Family Medicine — Payments: $518.07
Family Medicine $518.07
David Afzal, Do, DO
Family Medicine — Payments: $444.16
Family Medicine $444.16